On the contrary, a recent study demonstrated that SIRT5 desuccinylates GLS at residue K164, stabilizing and protecting it from ubiquitin-mediated degradation and that SIRT5 expression promotes the proliferation and tumorigenesis of MDA-MB-231 breast cancer cells [76]. Here, SIRT5 is linked to breast carcinoma.